drugset / Trial / NCT05515523

Stromal Vascular Fraction (SVF) for Knee Post-Trauma Osteoarthritis (PTOA)

NCT05515523 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, non-randomized, interventional, dual site, before-after clinical trial to determine feasibility and safety of a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF) for the treatment of knee Post Traumatic Osteoarthritis (PTOA).

Timeline

Start
2026-02
Primary completion
2027-11
Completion
2027-11

Outcome

Outcome not reported

Stopped (Business): “Lack of Funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipose Derived (AD) Stromal Vascular Fraction (SVF) Cell therapy — Other

Indications